Founded

Address

Flagship Ventures
One Memorial Drive
7th Floor
Cambridge, MA 02142
United States

Open map


Recent investment activity

KANDO id: 30843

Corporate information

Founders
Registration country

Company type

Venture capital firm

Relation

Renamed to

Funding rounds

Investment preferences

Top investment portfolio themes
software (1)  
healthcare (1)  

Actual initial investment stage
N/A (3)

Investment activity status
Not investing

Selected investments

Displaying 51 - 75 of 89
Profile Country Date Funding
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. Series C
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. Series A
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. N/A
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. Series B
VisEn Medical Inc A fluorescence molecular imaging technology company developing fluorescence-based agents and systems for non-invasive imaging. N/A
Visterra Inc A biotechnology company discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. N/A
Zalicus Inc Combination drug development N/A
Ze-gen Inc A renewable energy company developing advanced gasification technology to convert waste into synthesis gas. N/A
Zoom Information Inc (ZoomInfo) The premier business information search engine, with profiles on more than 37 million people and 3.5 million companies across virtually every industry N/A
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series F Follow-on investment
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series D Follow-on investment
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series C Initial investment
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series B
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. N/A
Accuri Cytometers Inc N/A
Adolor Corp N/A
Advanced Electron Beams Inc (AEB) Provider of electron beam energy technology products and solutions worldwide. N/A
Alere Medical Inc A disease management company focused on internet-based medical monitoring systems for patients with chronic diseases. N/A
Alvine Pharmaceuticals Inc An innovative biopharmaceutical company developing biologics to target autoimmune/ inflammatory diseases. N/A
Anesta Corp A pharmaceutical company focused on powerful drug system to control the severe pain of end stage cancer. N/A
Arbor Networks Inc DDoS attack prevention, network security and visibility solutions company. N/A Initial investment
Aspect Medical Systems Inc Provider of of brain monitoring technology solutions. N/A
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. N/A
BDNA Corp Series D
Bind Biosciences Inc Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue Series B

Current team

Past employees

Selected Products / Customers

Financials